Toxicity Potential of Nutraceuticals

Methods Mol Biol. 2025:2834:197-230. doi: 10.1007/978-1-0716-4003-6_10.

Abstract

During the past few decades and especially during and after the COVID-19 pandemic, the use of nutraceuticals has become increasingly popular in both humans and animals due to their easy access, cost-effectiveness, and tolerability with a wide margin of safety. While some nutraceuticals are safe, others have an inherent toxic potential. For a large number of nutraceuticals, no toxicity/safety data are available due to a lack of pharmacological/toxicological studies. The safety of some nutraceuticals can be compromised via contamination with toxic plants, metals, mycotoxins, pesticides, fertilizers, drugs of abuse, etc. Knowledge of pharmacokinetic/toxicokinetic studies and biomarkers of exposure, effect, and susceptibility appears to play a pivotal role in the safety and toxicity assessment of nutraceuticals. Interaction studies are essential to determine efficacy, safety, and toxicity when nutraceuticals and therapeutic drugs are used concomitantly or when polypharmacy is involved. This chapter describes various aspects of nutraceuticals, particularly their toxic potential, and the factors that influence their safety.

Keywords: Drugs of abuse; Metals; Mycotoxins; Nutraceuticals; Pesticides; Plant alkaloids; Toxic nutraceuticals; Toxic potential; Toxicity testing models.

MeSH terms

  • Animals
  • Dietary Supplements* / toxicity
  • Humans